These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23361577)

  • 1. Swimming through the gut: implications of fluid transport on the microbiome.
    Colgan SP
    Dig Dis Sci; 2013 Mar; 58(3):602-3. PubMed ID: 23361577
    [No Abstract]   [Full Text] [Related]  

  • 2. Lubiprostone decreases mouse colonic inner mucus layer thickness and alters intestinal microbiota.
    Musch MW; Wang Y; Claud EC; Chang EB
    Dig Dis Sci; 2013 Mar; 58(3):668-77. PubMed ID: 23329012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.
    Bassil AK; Borman RA; Jarvie EM; McArthur-Wilson RJ; Thangiah R; Sung EZ; Lee K; Sanger GJ
    Br J Pharmacol; 2008 May; 154(1):126-35. PubMed ID: 18332851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon.
    Fei G; Wang YZ; Liu S; Hu HZ; Wang GD; Qu MH; Wang XY; Xia Y; Sun X; Bohn LM; Cooke HJ; Wood JD
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G823-32. PubMed ID: 19179625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.
    Moeser AJ; Nighot PK; Engelke KJ; Ueno R; Blikslager AT
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G647-56. PubMed ID: 17053162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.
    Sweetser S; Busciglio IA; Camilleri M; Bharucha AE; Szarka LA; Papathanasopoulos A; Burton DD; Eckert DJ; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G295-301. PubMed ID: 19033530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
    Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
    J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.
    Bijvelds MJ; Bot AG; Escher JC; De Jonge HR
    Gastroenterology; 2009 Sep; 137(3):976-85. PubMed ID: 19454284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.
    MacDonald KD; McKenzie KR; Henderson MJ; Hawkins CE; Vij N; Zeitlin PL
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L933-40. PubMed ID: 18805957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.
    Ao M; Venkatasubramanian J; Boonkaewwan C; Ganesan N; Syed A; Benya RV; Rao MC
    Dig Dis Sci; 2011 Feb; 56(2):339-51. PubMed ID: 21140215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. May the truth be with you: lubiprostone as EP receptor agonist/ClC-2 internalizing "inhibitor".
    Akiba Y; Kaunitz JD
    Dig Dis Sci; 2012 Nov; 57(11):2740-2. PubMed ID: 23001408
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.
    Ginzburg R; Ambizas EM
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1091-7. PubMed ID: 18680443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lubiprostone: a chloride channel activator.
    Lacy BE; Levy LC
    J Clin Gastroenterol; 2007 Apr; 41(4):345-51. PubMed ID: 17413599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia.
    Schiffhauer ES; Vij N; Kovbasnjuk O; Kang PW; Walker D; Lee S; Zeitlin PL
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L324-31. PubMed ID: 23316067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility.
    Jakab RL; Collaco AM; Ameen NA
    Dig Dis Sci; 2012 Nov; 57(11):2826-45. PubMed ID: 22923315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lubiprostone targets prostanoid EP₄ receptors in ovine airways.
    Cuthbert AW
    Br J Pharmacol; 2011 Jan; 162(2):508-20. PubMed ID: 20883477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4)).
    Norimatsu Y; Moran AR; MacDonald KD
    Biochem Biophys Res Commun; 2012 Sep; 426(3):374-9. PubMed ID: 22960173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
    Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lubiprostone stimulates small intestinal mucin release.
    De Lisle RC
    BMC Gastroenterol; 2012 Nov; 12():156. PubMed ID: 23130661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.
    Joo NS; Wine JJ; Cuthbert AW
    Am J Physiol Lung Cell Mol Physiol; 2009 May; 296(5):L811-24. PubMed ID: 19233902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.